WARF ADVANCES
Top licensing prospects from the University of Wisconsin-Madison
Nanoparticle to Render Tumors More Susceptible to Treatment
This interdisciplinary team is bridging medicine and nanotechnology to confront cancer. The combination of their novel nanoparticle, radiation therapy and a checkpoint inhibitor could render more tumors more treatable by immunotherapy.
Watch a video
Polyplex Delivery System for Proteins, Nucleic Acids and Protein/Nucleic Acid Complexes
A UW team developed an improved biocompatible polyplex that can successfully deliver large biomolecular payloads (e.g., S1mplex, RNP with a single-stranded oligonucleotide DNA donor template) into cells.
Read more
Airflow Monitor
Death and injury to patients under conscious sedation can be prevented. This novel respiratory monitoring device – developed by two physicians – can detect airway compromise early, quantitatively and in real time.
Read more and watch a video
WARF T Cell and Immunotherapy Portfolio
UW-Madison is an international leader in T cell innovations. From expanding and activating T cells to quality control and manufacturing, we bring solutions to industry.
Read more
Optimizing the Use of Contrast Agents During Medical Imaging
A medical physicist has developed an automatable solution to quantify contrast enhancement, which allows contrast prescriptions to be customized so sites can provide patients with the appropriate minimum volume while minimizing waste.
Read more
Wearable Tendon Force Measurement
This wearable device for in-field, mobile analysis of tendon strength helps with sports injury recovery and prevention by using tendon tensiometry to detect changes in tendon tension and correlating that data to gait and limb strength to detect abnormalities.
Watch a video
Neurosetta Brain and Spinal Cord Models
Neurosetta’s high-throughput human brain and spinal cord modeling platform is transforming developmental neurotoxicity (DNT) testing and drug development for neurodevelopmental disorders.
Watch a video
Molecular Sleep Test
Meet UW researchers developing a first-of-its-kind molecular sleep test based on an epigenetic discovery.
Watch a video
Read about more licensing prospects!
In the News
- Venture spotlight: Leo Cancer Care
- When every minute counts: Atrility Medical
- New injectable gel offers promise for tough-to-treat brain tumors
- Brain imaging reveals how mindfulness program boosts pain regulation
- New nanoparticles aid sepsis treatment in mice
- Cellular Logistics seeking new round of financing
- Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression